Biotech Investors: August's Key PDUFA Catalysts You Must Know

Regulatory decisions have yet to pick up pace this year. July’s calendar was light, but the good news was that most decisions turned out to ...

Related Keywords

China , ,Glaxosmithkline ,Psychopharmacologic Drugs Advisory Committee ,Amicus Therapeutics Inc ,Nasdaq ,Pfizer ,Pfizer Inc ,Pharmaceuticals Inc ,Gene Therapies Advisory Committee ,Incyte Corporation ,Horizon Therapeutics Ltd ,Regeneron Pharmaceuticals Inc ,Drug Administration ,Beigene Ltd ,Myovant Sciences Ltd ,Cormedix Inc ,Amgen Inc ,Diseases That Could Emerge As Potent ,Drugs Advisory Committee ,Month Wait Worth ,Myovant Sciences ,Teladoc Health ,Revised Outlook ,Implies More Downside According To This ,No Go For Amicu Pompe ,Amicus Therapeutics ,Evaluate Pharma ,Regeneron Pharmaceuticals ,